Zoetis has relaunched a broad spectrum intramammary treatment for clinical mastitis, as Lincocin Forte S.

For vets seeking to prescribe an alternative first-choice tube, independent mastitis authority Dr Andrew Bradley suggests it could be a logical…

Zoetis has announced that Suvaxyn MH-One, its vaccine against Mycoplasma hyopneumoniae in pigs, has a revised licence allowing it to be administered from seven days of age with a two-week onset of immunity.

The company says this means that piglets can…

Zoetis has launched Suvaxyn Parvo/E, a combined vaccine which it says provides the earliest protection of gilts against parvovirus and erysipelas.

Parvovirus and erysipelas infections occur primarily in gilts and sows, negatively impacting their reproductive…

Zoetis has announced the availability in the UK and Ireland of Poulvac IBQX, the first specific vaccine against the QX strain of the infectious bronchitis virus.

For the past two years the vaccine has only been available with a special import certificate…

Zoetis has launched a new high precision treatment gun for single-handed low volume subcutaneous injections.

The gun handles medications up to 5ml per treatment. The company says it is designed for use with its long acting moxidectin injectable wormer…

Zoetis has announced the launch of Zulvac SBV, a new Schmallenberg vaccine licensed for use in cattle and sheep in two doses at a three week interval, the second at least two weeks before mating.

Zulvac SBV is licensed for use in cattle and sheep in two…

Zoetis has launched a one-dose vial of Rispoval IntraNasal, in order to offer respiratory health protection in calves as soon as possible after birth without either waiting to batch them in groups or wasting unused vaccine in multi-dose packs.

To make…

Zoetis has announced that a batch of the bluetongue vaccines, Zulvac® 8 Bovis and Zulvac® 8 Ovis, is expected to become available to veterinary practices in mid-July, in time to manage the risk of an outbreak predicted by Defra to reach mainland UK by…

Zoetis has launched Cefshot, a first generation cephalosporin dry cow intramammary antibiotic.

Cefshot is indicated for treatment of subclinical mastitis at drying off with action against Gram positive and Gram negative bacteria.

Jude Roberts MRCVS…

Zoetis UK Ltd has issued a recall of Cefshot DC 250mg Intramammary Suspension for Cattle.

According to the Veterinary Medicines Directorate, the company has identified that there is a small possibility that some syringes from the batches listed below…

Zoetis has announced the EU launch of Suvaxyn PRRS MLV, a novel vaccine containing a modified live European Porcine Reproductive and Respiratory Syndrome (PRRS) virus strain, grown in a unique cell line for whole herd protection against PRRS.

Suvaxyn…

Zoetis has announced the European launch of Suvaxyn Circo, a new monovalent killed virus vaccine which the company says reduces viral load in blood and in lymphoid tissues as well as faecal shedding caused by infection with PCV2.

The vaccine has been…

Zoetis has announced that the European Commission has granted the company marketing authorization for CircoMax Myco for the active immunisation of pigs against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae.

The company says that CircoMax…

Zoetis has launched CircoMax Myco, billed as the first and only vaccine that includes two porcine circovirus type 2 (PCV2) genotypes (a & b), providing broader coverage against PCV2 and the longest-lasting combined protection against two of the main pathogens…

Zoetis has ramped up production of its Marek’s disease vaccine.

Poulvac CVI + HVT Marek’s vaccine provides the combination of the Rispens CVI strain and the HVT strain.

Zoetis says this combination of serotypes has long been recognised for…